157 related articles for article (PubMed ID: 6575865)
1. Synthesis, antitumor activity, and cardiac toxicity of new 4-demethoxyanthracyclines.
Penco S; Casazza AM; Franchi G; Barbieri B; Bellini O; Podestà A; Savi G; Pratesi G; Geroni C; Di Marco A; Arcamone F
Cancer Treat Rep; 1983; 67(7-8):665-73. PubMed ID: 6575865
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activity of 4-demethoxyadriamycin and 4-demethoxy-4' -epiadriamycin.
Di Marco A; Casazza AM; Giuliani F; Pratesi G; Arcamone F; Bernardi L; Franchi G; Giardino P; Patelli B; Penco S
Cancer Treat Rep; 1978 Mar; 62(3):375-80. PubMed ID: 647696
[TBL] [Abstract][Full Text] [Related]
3. Experimental evaluation of anthracycline analogs.
Casazza AM
Cancer Treat Rep; 1979 May; 63(5):835-44. PubMed ID: 455325
[TBL] [Abstract][Full Text] [Related]
4. Antitumor spectrum of a new anthracycline, (2"R)-4'-O-tetrahydropyranyladriamycin, and effect on the cellular immune response in mice.
Hisamatsu T; Suzuki K; Sakakibara S; Komuro K; Nagasawa M; Takeuchi T; Umezawa H
Jpn J Cancer Res; 1985 Oct; 76(10):1008-20. PubMed ID: 3935619
[TBL] [Abstract][Full Text] [Related]
5. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
[TBL] [Abstract][Full Text] [Related]
6. Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
Dawson KM
Cancer Res; 1983 Jun; 43(6):2880-3. PubMed ID: 6573953
[TBL] [Abstract][Full Text] [Related]
7. Treatment of mouse tumors with 7-con-O-methylnogarol and other analogs of the anthracycline antibiotic, nogalamycin.
Neil GL; Kuentzel SL; McGovren JP
Cancer Treat Rep; 1979; 63(11-12):1971-8. PubMed ID: 526931
[TBL] [Abstract][Full Text] [Related]
8. New doxorubicin analogs active against doxorubicin-resistant colon tumor xenografts in the nude mouse.
Giuliani FC; Kaplan NO
Cancer Res; 1980 Dec; 40(12):4682-7. PubMed ID: 7438099
[TBL] [Abstract][Full Text] [Related]
9. Single-strand DNA breaks induced by chromophore-modified anthracyclines in P388 leukemia cells.
Capranico G; Soranzo C; Zunino F
Cancer Res; 1986 Nov; 46(11):5499-503. PubMed ID: 3463414
[TBL] [Abstract][Full Text] [Related]
10. Influence of the structure of new anthracycline antibiotics on their biological properties.
Wasowska M; Oszczapowicz I; Wietrzyk J; Opolski A; Madej J; Dzimira S; Oszczapowicz J
Anticancer Res; 2005; 25(3B):2043-8. PubMed ID: 16158943
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers.
Arcamone F; Bernardi L; Giardino P; Patelli B; Marco A; Casazza AM; Pratesi G; Reggiani P
Cancer Treat Rep; 1976 Jul; 60(7):829-34. PubMed ID: 1009518
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of 1-nitro-9-aminoacridines including nitracrine against some ascitic experimental tumors.
Mazerska Z; Lukowicz J; Konopa J
Arzneimittelforschung; 1990 Apr; 40(4):472-7. PubMed ID: 2357249
[TBL] [Abstract][Full Text] [Related]
13. 4-Demethoxy-3'-N-trifluoroacetyldoxorubicin. Synthesis and solid tumor activity.
Horton D; Priebe W; Carter JP; Filppi J; Wolgemuth RL
Drug Des Deliv; 1990 Jun; 6(2):123-9. PubMed ID: 2080980
[TBL] [Abstract][Full Text] [Related]
14. The antineoplastic activity of 4'-deoxydoxorubicin in murine solid tumors.
Marmonti L; Jin XQ; Filippeschi S; Spreafico F
Anticancer Res; 1984; 4(6):425-9. PubMed ID: 6517535
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
16. Anthracycline antibiotics with high liposome entrapment: structural features and biological activity.
Perez-Soler R; Priebe W
Cancer Res; 1990 Jul; 50(14):4260-6. PubMed ID: 2194651
[TBL] [Abstract][Full Text] [Related]
17. Anthrapyrazoles, a new class of intercalating agents with high-level, broad spectrum activity against murine tumors.
Leopold WR; Nelson JM; Plowman J; Jackson RC
Cancer Res; 1985 Nov; 45(11 Pt 1):5532-9. PubMed ID: 4053027
[TBL] [Abstract][Full Text] [Related]
18. Increased therapeutic efficacy and reduced toxicity of doxorubicin linked to pyran copolymer via the side chain of the drug.
Zunino F; Pratesi G; Pezzoni G
Cancer Treat Rep; 1987 Apr; 71(4):367-73. PubMed ID: 3829013
[TBL] [Abstract][Full Text] [Related]
19. [New anthracycline antibiotics and derivatives].
Tatsuta K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
[TBL] [Abstract][Full Text] [Related]
20. 4'-O-tetrahydropyranyladriamycin as a potential new antitumor agent.
Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
Cancer Res; 1982 Apr; 42(4):1462-7. PubMed ID: 7060020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]